Founded in 1926, the Seth Gordhandas Sunderdas Medical College (GSMC) and the King Edward Memorial (KEM) Hospital are amongst the foremost teaching and medical care providing institutions in India. The medical college (school) provides training to about 2000 students in undergraduate, postgraduate and super-speciality medical courses; in undergraduate and postgraduate physical and occupational therapy; and Masters and PhD courses in various allied specialties. A nursing school is also maintained by these institutions. With about 390 staff physicians and 550 resident doctors, the 1800 bedded hospital treats about 1.8 million out-patients and 85,000 in-patients annually and provides both basic care and advanced treatment facilities in all fields of medicine and surgery. Funded mainly by the Municipal Corporation of Greater Mumbai, these institutions render yeomen service – virtually free of cost – mostly to the underprivileged sections of the society.
Main roles in project
We will conduct phase IV clinical research studies using an already marketed quadrivalent influenza vaccine (QIV) in elderly (QIV-1 study) and in infants/children (QIV-2 study). At a later stage, once the phase I trial of COBRA vaccine is completed in Europe, we will be conducting the phase II COBRA vaccine study in India. The biological samples collected during these studies will be used by our laboratory partners within the consortium to compare the immune profiling between the QIV and COBRA vaccine. GSMC & KEM will also contribute to the management and coordination of the consortium as a work package leader.
Contact: Dr. Nithya Gogtay
This project has received funding from the European Union H2020 (grant no. 874866) and the Dept. of Biotechnology, Govt. of India (project no. BT/IN/EU-INF/16/AP/19-20/11746)